Literature DB >> 24043900

Heat shock transcription factor 1 is activated as a consequence of lymphocyte activation and regulates a major proteostasis network in T cells critical for cell division during stress.

Siva K Gandhapudi1, Patience Murapa, Zachary D Threlkeld, Martin Ward, Kevin D Sarge, Charles Snow, Jerold G Woodward.   

Abstract

Heat shock transcription factor 1 (HSF1) is a major transcriptional regulator of the heat shock response in eukaryotic cells. HSF1 is evoked in response to a variety of cellular stressors, including elevated temperatures, oxidative stress, and other proteotoxic stressors. Previously, we demonstrated that HSF1 is activated in naive T cells at fever range temperatures (39.5°C) and is critical for in vitro T cell proliferation at fever temperatures. In this study, we demonstrated that murine HSF1 became activated to the DNA-binding form and transactivated a large number of genes in lymphoid cells strictly as a consequence of receptor activation in the absence of apparent cellular stress. Microarray analysis comparing HSF1(+/+) and HSF1(-/-) gene expression in T cells activated at 37°C revealed a diverse set of 323 genes significantly regulated by HSF1 in nonstressed T cells. In vivo proliferation studies revealed a significant impairment of HSF1(-/-) T cell expansion under conditions mimicking a robust immune response (staphylococcal enterotoxin B-induced T cell activation). This proliferation defect due to loss of HSF1 is observed even under nonfebrile temperatures. HSF1(-/-) T cells activated at fever temperatures show a dramatic reduction in cyclin E and cyclin A proteins during the cell cycle, although the transcription of these genes was modestly affected. Finally, B cell and hematopoietic stem cell proliferation from HSF1(-/-) mice, but not HSF1(+/+) mice, were also attenuated under stressful conditions, indicating that HSF1 is critical for the cell cycle progression of lymphoid cells activated under stressful conditions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24043900      PMCID: PMC4520533          DOI: 10.4049/jimmunol.1202831

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  79 in total

1.  T cell-dependent maturation of dendritic cells in response to bacterial superantigens.

Authors:  Eric Muraille; Carl De Trez; Bernard Pajak; Maryse Brait; Jacques Urbain; Oberdan Leo
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

2.  Analysis of the in vivo dendritic cell response to the bacterial superantigen staphylococcal enterotoxin B in the mouse spleen.

Authors:  S Yoon; K L Bae; J Y Shin; H J Yoo; H W Lee; S Y Baek; B S Kim; J B Kim; H D Lee
Journal:  Histol Histopathol       Date:  2001-10       Impact factor: 2.303

3.  Discovery of the heat shock response.

Authors:  F Ritossa
Journal:  Cell Stress Chaperones       Date:  1996-06       Impact factor: 3.667

4.  Inhibition of tumor necrosis factor-alpha transcription in macrophages exposed to febrile range temperature. A possible role for heat shock factor-1 as a negative transcriptional regulator.

Authors:  I S Singh; R M Viscardi; I Kalvakolanu; S Calderwood; J D Hasday
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

5.  Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor.

Authors:  S C Hong; G Waterbury; C A Janeway
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

6.  Mouse heat shock transcription factors 1 and 2 prefer a trimeric binding site but interact differently with the HSP70 heat shock element.

Authors:  P E Kroeger; K D Sarge; R I Morimoto
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  In vitro activation of heat shock transcription factor DNA-binding by calcium and biochemical conditions that affect protein conformation.

Authors:  D D Mosser; P T Kotzbauer; K D Sarge; R I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 8.  Dynamic remodeling of transcription complexes by molecular chaperones.

Authors:  Richard I Morimoto
Journal:  Cell       Date:  2002-08-09       Impact factor: 66.850

9.  Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.

Authors:  Chengkai Dai; Luke Whitesell; Arlin B Rogers; Susan Lindquist
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

10.  T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.

Authors:  T Miethke; C Wahl; K Heeg; B Echtenacher; P H Krammer; H Wagner
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Molecular Mechanisms of Heat Shock Factors in Cancer.

Authors:  Mikael Christer Puustinen; Lea Sistonen
Journal:  Cells       Date:  2020-05-12       Impact factor: 6.600

2.  Clinical significance and potential mechanism of heat shock factor 1 in acute myeloid leukemia.

Authors:  Chunyi Lyu; Qian Wang; Xuewei Yin; Zonghong Li; Teng Wang; Yan Wang; Siyuan Cui; Kui Liu; Zhenzhen Wang; Chang Gao; Ruirong Xu
Journal:  Aging (Albany NY)       Date:  2022-09-06       Impact factor: 5.955

3.  Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer.

Authors:  Marie Pariollaud; Lara H Ibrahim; Emanuel Irizarry; Rebecca M Mello; Alanna B Chan; Brian J Altman; Reuben J Shaw; Michael J Bollong; R Luke Wiseman; Katja A Lamia
Journal:  Sci Adv       Date:  2022-09-28       Impact factor: 14.957

Review 4.  Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy.

Authors:  Sungmin Lee; Beomseok Son; Gaeul Park; Hyunwoo Kim; Hyunkoo Kang; Jaewan Jeon; HyeSook Youn; BuHyun Youn
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

Review 5.  The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors.

Authors:  Yi Cheng; Shanshan Weng; Linzhen Yu; Ning Zhu; Mengyuan Yang; Ying Yuan
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.